| Blood coagulation factor XIII: structure and function L Muszbek, VC Yee, Z Hevessy Thrombosis research 94 (5), 271-305, 1999 | 433 | 1999 |
| The emerging value of P-selectin as a disease marker J Kappelmayer, B Nagy Jr, K Miszti-Blasius, Z Hevessy, H Setiadi Clinical Chemistry and Laboratory Medicine (CCLM) 42 (5), 475-486, 2004 | 143 | 2004 |
| Deficiency causing mutations and common polymorphisms in the factor XIII-A gene L Muszbek Thrombosis and Haemostasis 84 (10), 524-527, 2000 | 47 | 2000 |
| Promotion of the crosslinking of fibrin and α2-antiplasmin by platelets Z Hevessy, G Haramura, Z Boda, M Udvardy, L Muszbek Thrombosis and haemostasis 75 (01), 161-167, 1996 | 43 | 1996 |
| Frequency of the TAFI–438 G/A and factor XIIIA Val34Leu polymorphisms in patients with objectively proven pulmonary embolism M Zidane, MCH de Visser, M ten Wolde, HL Vos, W de Monyé, RM Bertina, ... Thrombosis and haemostasis 90 (09), 439-445, 2003 | 39 | 2003 |
| Pathogenicity and virulence of coagulase negative staphylococci in relation to adherence, hydrophobicity, and toxin production in vitro. C Molnar, Z Hevessy, F Rozgonyi, CG Gemmell Journal of clinical pathology 47 (8), 743-748, 1994 | 35 | 1994 |
| Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A F Kiss, Z Hevessy, A Veszprémi, É Katona, C Kiss, G Vereb, L Muszbek, ... Thrombosis and haemostasis 96 (08), 176-182, 2006 | 31 | 2006 |
| An extensive quality control and quality assurance (QC/QA) program significantly improves inter-laboratory concordance rates of flow-cytometric minimal residual disease … M Maurer-Granofszky, A Schumich, B Buldini, G Gaipa, J Kappelmayer, ... Cancers 13 (23), 6148, 2021 | 28 | 2021 |
| Extensive epigenetic and transcriptomic variability between genetically identical human B-lymphoblastoid cells with implications in pharmacogenomics research L Ozgyin, A Horvath, Z Hevessy, BL Balint Scientific reports 9 (1), 4889, 2019 | 22 | 2019 |
| Serum thymidine kinase activity: analytical performance, age-related reference ranges and validation in chronic lymphocytic leukemia E Szánthó, HP Bhattoa, M Csobán, P Antal-Szalmás, A Ujfalusi, ... PLoS One 9 (3), e91647, 2014 | 20 | 2014 |
| Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia Á Simon, Z Bagoly, Z Hevessy, L Csáthy, É Katona, G Vereb, A Ujfalusi, ... Cytometry Part B: Clinical Cytometry 82 (4), 209-216, 2012 | 20 | 2012 |
| Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies F Magyari, LI Pinczés, E Páyer, K Farkas, S Ujfalusi, Á Diószegi, M Sik, ... Annals of hematology 101 (10), 2337-2345, 2022 | 19 | 2022 |
| A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII F Kiss, A Simon, L Csáthy, Z Hevessy, E Katona, C Kiss, J Kappelmayer Cytometry Part A: the journal of the International Society for Analytical …, 2008 | 17 | 2008 |
| Progress in defining multidrug resistance in leukemia J Kappelmayer, A Simon, F Kiss, Z Hevessy Expert Review of Molecular Diagnostics 4 (2), 209-217, 2004 | 17 | 2004 |
| α2-Plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study Z Hevessy, A Patthy, L Kárpáti, L Muszbek Thrombosis research 99 (4), 399-406, 2000 | 17 | 2000 |
| Comparative analysis of multicolor flow cytometry and immunohistochemistry for the detection of disseminated tumor cells E Szánthó, B Kárai, G Ivády, J Bedekovics, I Szegedi, M Petrás, G Ujj, ... Applied Immunohistochemistry & Molecular Morphology 26 (5), 305-315, 2018 | 14 | 2018 |
| Immunoassays for diagnosis of coagulation disorders A Kappel, M Ehm Hämostaseologie 30 (04), 194-201, 2010 | 12 | 2010 |
| Mean fluorescence intensity rate is a useful marker in the detection of paroxysmal nocturnal hemoglobinuria clones Z Hevessy, B Nagy Jr, F Kiss, A Kiss, J Kappelmayer Clinical Chemistry and Laboratory Medicine (CCLM) 43 (9), 919-923, 2005 | 12 | 2005 |
| A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots B Kárai, M Habók, G Reményi, L Rejtő, A Ujfalusi, J Kappelmayer, ... Annals of hematology 98, 1413-1420, 2019 | 11 | 2019 |
| The impact of delayed sample handling and type of anticoagulant on the interpretation of dysplastic signs detected by flow cytometry B Kárai, Z Miltényi, L Gergely, M Száraz-Széles, J Kappelmayer, ... Biochemia Medica 28 (2), 296-308, 2018 | 11 | 2018 |
